News Focus
News Focus
icon url

flipper44

11/27/20 6:12 AM

#333623 RE: flipper44 #333622

NWBO should get a response from the patent office in about one month.
icon url

eagle8

11/27/20 6:56 AM

#333626 RE: flipper44 #333622


Thanks flipper for sharing.

GLTU
icon url

Survivor2012

11/27/20 7:01 AM

#333627 RE: flipper44 #333622

Wow, a lot of time and effort to get this done!
icon url

greenJack

11/27/20 7:15 AM

#333628 RE: flipper44 #333622

Impressive work/find, both of NWBO as of flipper44
icon url

Basin Street Blues

11/27/20 7:18 AM

#333629 RE: flipper44 #333622

Ilkley Moor is in North Yorks BTW
icon url

Basin Street Blues

11/27/20 7:18 AM

#333630 RE: flipper44 #333622

You know that find alone should be worth at least +10cents on todays price .....however everyone is exhausted mentally and probably financially.

icon url

Lykiri

11/27/20 7:30 AM

#333631 RE: flipper44 #333622

flipper44,

Thank you!
icon url

sukus

11/27/20 8:09 AM

#333635 RE: flipper44 #333622

Thanks Flipper for pointing this out about the potentially very important patent.
icon url

vortmaximum

11/27/20 8:17 AM

#333636 RE: flipper44 #333622

A whole lot of lawyer-ing going on....
icon url

tryn2

11/27/20 8:39 AM

#333639 RE: flipper44 #333622

This board is informative like it is because of the hard work of you and a few others.... thank you flip for that.... the mountains of insightful information you have found has enlightened us all...
icon url

forumreader35

11/27/20 9:01 AM

#333648 RE: flipper44 #333622

Good stuff Flipper,

It would seem they are patenting the use of IL-6, -8, -12 and/ or TNFa as markers of sufficiently matured dendritic cells (without need of comparison of immature); versus patent examiner earlier rejected as a comparison for matured vs immatured via IL-8, -12 as markers only

Strength of this would be in whether having these 4 markers analyzed, specifically, is the best bet or another combination is just as sufficient (i.e. there were supposedly 15 markers that can help predict). One would think Northwest picked the best/ most predictive for consistent outcome (that matured dendritic cells in this way were linked with good patient outcome). The fact they are patenting this analysis is great for Direct in that they can optimize for response in future trials (similar benefit of a PD-L1 test prior to PD-1 treatment) - if matured cells in this manner more likely patient's immune system properly trained by their dendritic cells to attack tumor.
icon url

Dr Bala

11/27/20 9:18 AM

#333654 RE: flipper44 #333622

Great find, Flip.
icon url

Uranium

11/27/20 9:19 AM

#333656 RE: flipper44 #333622

Great find flipper! Is this patent something they’d be waiting for before announcing TLD?
icon url

anders2211

11/27/20 9:35 AM

#333667 RE: flipper44 #333622

thanks flipper super interesting good find
icon url

ATLnsider

11/27/20 11:30 AM

#333704 RE: flipper44 #333622

Thank you flipper44
icon url

martyDg

11/28/20 2:13 PM

#333925 RE: flipper44 #333622

Thanks for the finding. NWBO is definitely busy on both D & L
icon url

Doc logic

11/29/20 3:51 PM

#334084 RE: flipper44 #333622

flipper44,

Thanks! One more duck getting into line. Been wondering for a while now when the next steps for this patent application would be made so future trial results don’t get ahead of patent protection. They don’t want to get too specific where the application of tweaks would require more specificity in their patent application which in turn would lead to more competition down the road and knockoffs in countries that do not provide patent protection now. The secret sauce needs to stay the secret sauce as much as possible. Best wishes.